Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Gains from Sales and Divestitures (2016 - 2020)

Historic Gains from Sales and Divestitures for Myriad Genetics (MYGN) over the last 6 years, with Q2 2020 value amounting to $900000.0.

  • Myriad Genetics' Gains from Sales and Divestitures rose 1250.0% to $900000.0 in Q2 2020 from the same period last year, while for Jun 2020 it was $900000.0, marking a year-over-year increase of 1250.0%. This contributed to the annual value of $900000.0 for FY2020, which is 1250.0% up from last year.
  • As of Q2 2020, Myriad Genetics' Gains from Sales and Divestitures stood at $900000.0, which was up 1250.0% from $900000.0 recorded in Q1 2020.
  • Myriad Genetics' 5-year Gains from Sales and Divestitures high stood at $900000.0 for Q4 2019, and its period low was $400000.0 during Q1 2016.
  • Moreover, its 5-year median value for Gains from Sales and Divestitures was $700000.0 (2017), whereas its average is $620000.0.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first skyrocketed by 195128.21% in 2016, then changed by 0.0% in 2017.
  • Myriad Genetics' Gains from Sales and Divestitures (Quarter) stood at $400000.0 in 2016, then soared by 75.0% to $700000.0 in 2017, then changed by 0.0% to $700000.0 in 2018, then increased by 28.57% to $900000.0 in 2019, then changed by 0.0% to $900000.0 in 2020.
  • Its Gains from Sales and Divestitures was $900000.0 in Q2 2020, compared to $900000.0 in Q1 2020 and $900000.0 in Q4 2019.